Literature DB >> 18782594

Community perspectives on the ethical issues surrounding adolescent HIV vaccine trials in South Africa.

Heather B Jaspan1, Nosiphiwo F Soka, Ann E Strode, Catherine Mathews, Daniella Mark, Alan J Flisher, Robin Wood, Linda-Gail Bekker.   

Abstract

Adolescents globally are at high risk for HIV acquisition and are the targets of HIV prevention interventions such as HIV vaccines. In order to understand stakeholders' attitudes towards the ethical issues of adolescent involvement in HIV vaccine trials, we conducted focus group discussions with key members of a semi-urban, informal Cape Town community with high HIV prevalence in which HIV vaccine trials are taking place. Themes were identified from focus group transcripts by four researchers, and included necessity of guardian consent, age of independent consent, and confidentiality of in-trial medical results. In general, ethical adolescent HIV vaccine trials will be feasible in this community.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782594      PMCID: PMC2590661          DOI: 10.1016/j.vaccine.2008.08.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  What makes clinical research in developing countries ethical? The benchmarks of ethical research.

Authors:  Ezekiel J Emanuel; David Wendler; Jack Killen; Christine Grady
Journal:  J Infect Dis       Date:  2004-02-17       Impact factor: 5.226

2.  Use of community-based participatory research in preparing low income and homeless minority populations for future HIV vaccines.

Authors:  Adeline Nyamathi; Deborah Koniak-Griffin; Louise Tallen; Evelyn González-Figueroa; Lisa Levson; Yvonne Mosley; Ernestina Dominick; Nancy L R Anderson
Journal:  J Interprof Care       Date:  2004-11       Impact factor: 2.338

3.  Implications of the ethical-legal framework for adolescent HIV vaccine trials--report of a consultative forum.

Authors:  Catherine Slack; Ann Strode; Catherine Grant; Cecilia Milford
Journal:  S Afr Med J       Date:  2005-09

4.  Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads.

Authors:  Heather B Jaspan; Coleen K Cunningham; Tim J P Tucker; Peter F Wright; Steve G Self; Rebecca L Sheets; Audrey S Rogers; Linda-Gail Bekker; Craig M Wilson; Ann Duerr; Judith N Wasserheit
Journal:  J Acquir Immune Defic Syndr       Date:  2008-01-01       Impact factor: 3.731

5.  Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials.

Authors:  Heather B Jaspan; Jessica R Berwick; Landon Myer; Catherine Mathews; Alan J Flisher; Robin Wood; Linda-Gail Bekker
Journal:  J Adolesc Health       Date:  2006-07-31       Impact factor: 5.012

Review 6.  HIV vaccines in infants and children: past trials, present plans and future perspectives.

Authors:  Jeffrey T Safrit
Journal:  Curr Mol Med       Date:  2003-05       Impact factor: 2.222

7.  Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda.

Authors:  Noah Kiwanuka; Merlin Robb; Godfrey Kigozi; Deborah Birx; James Philips; Fred Wabwire-Mangen; Maria J Wawer; Fred Nalugoda; Nelson K Sewankambo; David Serwadda; Ronald H Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2004-06-01       Impact factor: 3.731

8.  Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa.

Authors:  Catherine Slack; Ann Strode; Theodore Fleischer; Glenda Gray; Chitra Ranchod
Journal:  BMC Med Ethics       Date:  2007-05-13       Impact factor: 2.652

  8 in total
  6 in total

1.  But is this really the 'parent' or 'guardian'? Practical strategies for consent to child research in South Africa.

Authors:  C M Slack; A E Strode
Journal:  S Afr J Bioeth Law       Date:  2016-02-15

2.  Retention of South African Adolescents in a 54-Month Longitudinal HIV Risk Reduction Trial.

Authors:  Larry D Icard; John B Jemmott; Craig Carty; Ann O'Leary; Lulama Sidloyi; Janet Hsu; JoAnn Tyler; Omar Martinez
Journal:  Prev Sci       Date:  2017-07

3.  A qualitative assessment of perspectives on the inclusion of adolescents in HIV vaccine trials in South Africa.

Authors:  H B Jaspan; N F Soka; C Mathews; A J Flisher; D Mark; K Middelkoop; R Wood; L-G Bekker
Journal:  Int J STD AIDS       Date:  2010-03       Impact factor: 1.359

Review 4.  Preventing HIV among young people: research priorities for the future.

Authors:  Audrey Pettifor; Linda-Gail Bekker; Sybil Hosek; Ralph DiClemente; Molly Rosenberg; Sheana S Bull; Susannah Allison; Sinead Delany-Moretlwe; Bill G Kapogiannis; Frances Cowan
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

Review 5.  Adolescent participation in HIV research: consortium experience in low and middle-income countries and scoping review.

Authors:  Suzanne Day; Bill G Kapogiannis; Seema K Shah; Erin C Wilson; Theodore D Ruel; Donaldson F Conserve; Ann Strode; Geri R Donenberg; Pamela Kohler; Catherine Slack; Oliver Ezechi; Joseph D Tucker
Journal:  Lancet HIV       Date:  2020-12       Impact factor: 16.070

6.  Parental waivers to enable adolescent participation in certain forms of health research: lessons from a South African case study.

Authors:  Ann Strode; Zaynab Essack
Journal:  BMC Med Ethics       Date:  2022-09-24       Impact factor: 2.834

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.